1. Home
  2. ILAG vs PMCB Comparison

ILAG vs PMCB Comparison

Compare ILAG & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intelligent Living Application Group Inc.

ILAG

Intelligent Living Application Group Inc.

N/A

Current Price

$2.78

Market Cap

6.1M

ML Signal

N/A

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

N/A

Current Price

$0.42

Market Cap

6.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ILAG
PMCB
Founded
1981
1996
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1M
6.3M
IPO Year
2020
2001

Fundamental Metrics

Financial Performance
Metric
ILAG
PMCB
Price
$2.78
$0.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
748.0
★ 331.8K
Earning Date
04-24-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.33
52 Week High
$7.19
$1.51

Technical Indicators

Market Signals
Indicator
ILAG
PMCB
Relative Strength Index (RSI) 44.31 37.28
Support Level $2.60 $0.33
Resistance Level $3.32 $0.77
Average True Range (ATR) 0.10 0.05
MACD 0.02 0.00
Stochastic Oscillator 33.07 46.35

Price Performance

Historical Comparison
ILAG
PMCB

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Taiwan.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

Share on Social Networks: